All download files including the archive files are now in a publicly accessible Google Storage Bucket. Downloads page links have been updated.

Not found

Our G-nome assistant hasn't been able to find this symbol report. Please check the URL or use our search to find what you are looking for.

Symbol report for CXCL8

HGNC data for CXCL8

Approved symbol
CXCL8
Approved name

C-X-C motif chemokine ligand 8

Locus type
gene with protein product
HGNC ID
HGNC:6025
Symbol status
Approved
Previous symbols
IL8
Previous names
interleukin 8
chemokine (C-X-C motif) ligand 8
Alias symbols
SCYB8
LUCT
LECT
MDNCF
TSG-1
IL-8
NAP-1
3-10C
MONAP
AMCF-I
LYNAP
NAF
b-ENAP
GCP-1
K60
GCP1
NAP1
Alias names
neutrophil-activating peptide 1
granulocyte chemotactic protein 1
monocyte-derived neutrophil chemotactic factor
lung giant cell carcinoma-derived chemotactic protein
tumor necrosis factor-induced gene 1
monocyte-derived neutrophil-activating peptide
lymphocyte derived neutrophil activating peptide
beta endothelial cell-derived neutrophil activating peptide
alveolar macrophage chemotactic factor I
Chromosomal location
4q13.3
Alliance of Genome Resources
IUPHAR/BPS Guide to PHARMACOLOGY
821
The development of clinical signs of rheumatoid synovial inflammation is associated with increased synthesis of the chemokine CXCL8 (interleukin-8).
Kraan MC et al. Arthritis Res 2001 ;3(1)65-71
Kraan MC, Patel DD, Haringman JJ, Smith MD, Weedon H, Ahern MJ, Breedveld FC, Tak PP.
Arthritis Res 2001 ;3(1)65-71
Abstract: Paired synovial tissue samples were obtained from both clinically uninvolved (CU) and clinically involved (CI) knee joints of eight rheumatoid arthritis (RA) patients. In addition, biopsies were taken from five control subjects. We observed the expression of the chemokines CXCL8, CXCL9, CXCL10, CCL2 and CCL4 in CI and CU joints of RA patients. In particular, CXCL8 protein levels were specifically increased in CI joints compared with CU joints, which was confirmed by immunohistochemistry and in situ hybridization.
Assignment of the genes encoding human interleukin-8 receptor types 1 and 2 and an interleukin-8 receptor pseudogene to chromosome 2q35.
Morris SW et al. Genomics 1992 Nov;14(3)685-691
Morris SW, Nelson N, Valentine MB, Shapiro DN, Look AT, Kozlosky CJ, Beckmann MP, Cerretti DP.
Genomics 1992 Nov;14(3)685-691
Abstract: Two human cDNA clones that encode different interleukin-8 (IL8) receptors have recently been isolated. The interleukin-8 receptor type 1 (IL8R1) binds IL8 only, whereas the interleukin-8 receptor type 2 (IL8R2) (previously designated IL8RA) also binds growth regulated gene (GRO), and neutrophil activating protein-2 (NAP-2) with high affinity. In the process of screening a genomic library with these cDNAs to obtain large clones for use in chromosomal localization studies, we isolated an interleukin-8 receptor pseudogene (IL8RP) that bears greatest similarity to IL8R2. Using Southern hybridization analysis of human x rodent somatic cell hybrid DNAs with cDNA probes for IL8R1 and IL8R2 and probes from the IL8RP locus, we assigned the three loci to chromosome 2; fluorescence in situ hybridization (FISH) to metaphase chromosome preparations using genomic clones from each locus refined this localization to chromosome 2, band q35, for all three. By virtue of their chromosomal location, IL8R1 and IL8R2 may be considered candidate genes for several human disorders in which the involved locus has been mapped to distal 2q or that are associated with structural abnormalities of this segment, including van der Woude syndrome and the neoplastic diseases rhabdomyosarcoma and uterine leiomyomata. In addition, because this region of chromosome 2q is homologous to proximal mouse chromosome 1 in the segment containing the Lsh-Ity-Bcg locus involved in mediating host resistance to infection with intracellular pathogens, examination for abnormalities of the murine homologues of the IL8R genes should be considered in mice affected by mutations of this locus.